nejm semaglutide cardiovascular New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Nejm semiglutide | PDF
Description
On 2ndDecember 2025, the Delhi High Court declined to grant an interim injunction restraining Dr
As weight loss medications such as Ozempic become increasingly popular, it's important to understand the potential side effects associated with these treatments
Over a relatively short period, obesity and type 2 diabetes have come to represent a large medical and economic burden to global societies
In todays fast-evolving healthcare landscape, few trends are reshaping care delivery as rapidly as telehealth and the rise of GLP-1based treatments for weight management and diabetes
01375-3/asset/2a0aa5b3-9fde-4bd7-ad14-b865e6ec5eb5/main.assets/gr2_lrg.jpg)
